Friday Five – October 13, 2017

You are here

October 13, 2017

In this week’s Friday Five, MAXIMUS is reading about President Trump’s health care executive order and decision to stop making CSR payments, the ongoing effort to reauthorize expired CHIP funding, how health care spending and innovation impact each other, and West Virginia’s receipt of a Medicaid waiver to address substance abuse. 

1. Trump begins Obamacare dismantling with executive order

CNN reports the President signed an executive order focused on expanding access to both association health plans and short-term insurance policies. The order is widely seen as a strike against the Affordable Care Act, and has raised concerns that it would cause healthy people to abandon the ACA exchanges, ultimately resulting in significant price increases. 

2. Trump to end Obamacare insurer subsidies, putting pressure on Congress to act

In addition to the executive order, the Washington Examiner reports that the President has announced he will stop paying cost-sharing reduction subsidies to insurance companies. Insurance companies are still required to provide discounts to low-income customers and lawsuits are expected.

3. House GOP delays vote on children’s healthcare funding to negotiate with Dems 

Meanwhile, The Hill reports that Congress has still not reauthorized the Children’s Healthcare Insurance Program (CHIP), which expired September 30. The House has delayed a vote on the measure as they strive to reach a bipartisan agreement.

4. Can the US repair its healthcare while keeping its innovation edge?

This opinion piece in the New York Times examines the relationship between spending and innovation within the U.S. healthcare system, and whether healthcare reform would decrease investment and innovation. 

5. Medicaid to begin paying for 30-day drug treatment and naloxone

West Virginia received a waiver that will allow Medicaid to begin paying for 30-day stays at residential treatment centers, as well as methadone and naloxone (for overdoses). As reported by the Charleston Gazette-Mail, the waiver allows the state to test Medicaid coverage of different substance abuse treatment options.